Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid

NCT01634100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Probenecid
DRUG: Rifampicin
DRUG: Empagliflozin
DRUG: Empagliflozin
DRUG: Rifampicin
DRUG: Probenecid
DRUG: Empagliflozin (BI 10773)

Sponsor

Boehringer Ingelheim